HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min-Liang Kuo Selected Research

matrigel

12/2009Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway.
3/2006Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min-Liang Kuo Research Topics

Disease

70Neoplasms (Cancer)
07/2019 - 02/2002
25Neoplasm Metastasis (Metastasis)
01/2017 - 02/2003
13Stomach Neoplasms (Stomach Cancer)
01/2017 - 08/2005
12Carcinogenesis
01/2015 - 03/2003
10Breast Neoplasms (Breast Cancer)
07/2019 - 02/2003
9Lung Neoplasms (Lung Cancer)
01/2017 - 02/2003
8Adenocarcinoma of Lung
10/2015 - 01/2004
7Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 01/2005
7Carcinoma (Carcinomatosis)
10/2008 - 11/2002
6Hepatocellular Carcinoma (Hepatoma)
01/2017 - 02/2003
5Hypoxia (Hypoxemia)
12/2016 - 01/2005
5Basal Cell Carcinoma (Rodent Ulcer)
11/2013 - 12/2004
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2012 - 02/2003
4Inflammation (Inflammations)
09/2014 - 08/2004
4Ovarian Neoplasms (Ovarian Cancer)
08/2014 - 03/2004
3Squamous Cell Carcinoma of Head and Neck
04/2017 - 07/2014
3Colonic Neoplasms (Colon Cancer)
12/2016 - 07/2014
3Fibrosis (Cirrhosis)
09/2014 - 01/2013
3Lymphatic Metastasis
08/2011 - 11/2002
3Ascites
01/2011 - 03/2004
3Adenocarcinoma
08/2010 - 06/2007
3Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2005 - 03/2003
2Mouth Neoplasms (Oral Cancer)
01/2017 - 09/2013
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2014 - 12/2009
2Osteoporosis
10/2011 - 07/2007
2Leukemia
12/2009 - 01/2005
2Neuroblastoma
02/2006 - 03/2005
1Endometrial Neoplasms (Endometrial Cancer)
12/2015
1Acute Radiation Syndrome
09/2015
1Melanoma (Melanoma, Malignant)
04/2015
1Esophageal Squamous Cell Carcinoma
12/2014
1Reperfusion Injury
09/2014

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2003
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 11/2002
12Messenger RNA (mRNA)IBA
04/2017 - 02/2003
11Interleukin-6 (Interleukin 6)IBA
03/2013 - 11/2002
11NF-kappa B (NF-kB)IBA
02/2009 - 02/2003
10Connective Tissue Growth FactorIBA
07/2019 - 03/2004
8Vascular Endothelial Growth Factor CIBA
06/2014 - 02/2003
8Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2009 - 01/2004
6Biological ProductsIBA
12/2015 - 03/2004
6CytokinesIBA
03/2013 - 07/2004
5IntegrinsIBA
12/2012 - 03/2004
4Histone MethyltransferasesIBA
01/2017 - 10/2010
4GlucocorticoidsIBA
12/2012 - 10/2005
4Cysteine (L-Cysteine)FDA Link
06/2008 - 08/2005
3Peptides (Polypeptides)IBA
07/2019 - 06/2005
3MicroRNAs (MicroRNA)IBA
01/2017 - 09/2011
3CateninsIBA
12/2016 - 01/2015
3Cysteine-Rich Protein 61IBA
09/2014 - 11/2007
3Phosphotransferases (Kinase)IBA
06/2014 - 10/2008
3Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
06/2014 - 03/2006
3Pharmaceutical PreparationsIBA
11/2012 - 10/2005
3ResveratrolIBA
10/2011 - 01/2005
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2006 - 10/2005
3Dexamethasone (Maxidex)FDA LinkGeneric
02/2006 - 02/2003
3InterleukinsIBA
10/2005 - 07/2004
3EnzymesIBA
10/2005 - 08/2004
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
07/2019 - 06/2005
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 02/2006
2Angiopoietin-Like Protein 1IBA
01/2017 - 03/2013
2GlutaminaseIBA
01/2017 - 12/2016
2Plasminogen Activators (Plasminogen Activator)IBA
12/2016 - 06/2008
2Cadherins (E-Cadherin)IBA
12/2015 - 07/2013
2MethyltransferasesIBA
12/2015 - 08/2014
2Carrier Proteins (Binding Protein)IBA
04/2015 - 12/2009
2Conditioned Culture MediaIBA
01/2015 - 01/2014
2Biomarkers (Surrogate Marker)IBA
12/2014 - 01/2014
2LigandsIBA
05/2014 - 06/2009
2Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
05/2014 - 12/2012
2Chemokine ReceptorsIBA
11/2013 - 11/2007
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2012 - 11/2012
2RNA (Ribonucleic Acid)IBA
11/2012 - 02/2003
2Protein Isoforms (Isoforms)IBA
08/2011 - 01/2004
2collapsin response mediator protein-1IBA
08/2011 - 11/2008
2PaxillinIBA
02/2011 - 10/2008
2Benzo(a)pyreneIBA
08/2010 - 10/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2010 - 03/2004
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
12/2009 - 02/2003
2matrigelIBA
12/2009 - 03/2006
2Celecoxib (Celebrex)FDA Link
11/2008 - 02/2003
2Liposomes (Liposome)IBA
11/2007 - 08/2005
2Integrin alphaVbeta3IBA
06/2007 - 08/2005
1Glutamate-Cysteine LigaseIBA
01/2017
1Glutamic Acid (Glutamate)FDA Link
12/2016
1Glutamine (L-Glutamine)FDA Link
12/2016
1Small Interfering RNA (siRNA)IBA
09/2016
1Tetracycline (Achromycin)FDA LinkGeneric
12/2015
1Complement C1r (Complement Component 1r)IBA
12/2015
1G-Protein-Coupled Receptor KinasesIBA
11/2015
1MicellesIBA
09/2015
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2015
1Amifostine (Ethyol)FDA LinkGeneric
09/2015
1Insulin-Like Growth Factor II (Somatomedin A)IBA
04/2015
1AgarIBA
07/2014
1Leucovorin (Folinic Acid)FDA Link
07/2014
1Fluorouracil (Carac)FDA LinkGeneric
07/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2014

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2017 - 04/2009
4Therapeutics
06/2014 - 07/2007